S C Kussmaul

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs
    S C Kussmaul
    Pediatric Infectious Diseases, San Francisco Children s Hospital, University of California San Francisco, 500 Parnassus Avenue, San Francisco, CA 94143, USA
    Bone Marrow Transplant 45:1602-6. 2010

Collaborators

Detail Information

Publications1

  1. ncbi Safety of the live, attenuated varicella vaccine in pediatric recipients of hematopoietic SCTs
    S C Kussmaul
    Pediatric Infectious Diseases, San Francisco Children s Hospital, University of California San Francisco, 500 Parnassus Avenue, San Francisco, CA 94143, USA
    Bone Marrow Transplant 45:1602-6. 2010
    ..It appears safe to administer the LAVV to immunocompetent patients after HSCT. Prospective studies are needed to more accurately determine rates of vaccine complications, efficacy and immunologic responses to vaccination...